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Abstract 
OBJECTIVES: To examine trends in detection and survival of hollow viscus gastrointestinal 
neuroendocrine tumors (NETs) across time and geographic regions of the U.S. 
METHODS: We used the Surveillance, Epidemiology and End Results (SEER) database to 
investigate 19,669 individuals with newly diagnosed gastrointestinal NETs. Trends in incidence 
were tested using Poisson regression. Cox proportional hazards regression was used to 
examine survival.  
RESULTS: Incidence increased over time for NETs of all gastrointestinal sites (all P < 0.001), 
except appendix. Rates have risen faster for NETs of the small intestine and rectum than 
stomach and colon. Rectal NETs were detected at a faster pace among blacks than whites (P 
< 0.001) and slower in the East than other regions (P < 0.001). We observed that appendiceal 
and rectal NETs carry the best prognosis and survival of small intestinal and colon NETs has 
improved for both men and women. Colon NETs showed different temporal trends in sur-
vival according to geographic region (Pinteraction = 0.028). Improved prognosis was more con-
sistent across the country for small intestinal NETs. 
CONCLUSIONS: Incidence of gastrointestinal NETs has increased, accompanied by incon-
sistently improved survival for different anatomic sites among certain groups defined by race 
and geographic region. 
Key words: gastrointestinal neuroendocrine tumors, incidence, survival 
Introduction 
Carcinoid tumors of the gastrointestinal system 
are  slow-growing,  heterogeneous  neuroendocrine 
tumors  (NETs)  with  inconsistent  clinicopathologic 
and  biologic  character  [1].  The  wide  spectrum  of 
symptomatology of the disease has made it impossi-
ble  to  equate  all  gastrointestinal  NETs,  and  their 
treatment and prognosis are dependent on the ana-
tomical location of the found lesion in addition to its 
histology and size. To obscure matters further, the 7th 
AJCC TNM classification has led to a parallel staging 
system  from  the  established  European  Neuroendo-
crine Tumor Society (ENETS) [2]. 
 Behavioral  features  such  as  smoking  [3]  and 
genetic factors [4] have been implicated in the etiology 
of these lesions; however, clear causative factors have 
not yet been delineated. Although there are reports on 
the incidence and prevalence of gastrointestinal NETs, 
the purpose of our study was to examine trends in 
detection and survival of hollow viscus NETs across 
time and geographic regions in the United States us-
ing the Surveillance, Epidemiology and End Results 
(SEER) database [5]. Our study included only primary 
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NETs  diagnosed  between  1973  and  2008.  To  our 
knowledge  this  is  the  most  comprehensive  and 
up-to-date  retrospective  analysis  of  gastrointestinal 
NETs reported in the United States focusing on dif-
ferences according to gender, race/ethnicity, age, and 
geographic region. 
Materials and Methods 
 All  17  registries  of  the  National  Cancer  Insti-
tute’s  SEER  database  (1973-2008),  excluding  Hurri-
cane Katrina Impacted Louisiana Cases (cases diag-
nosed  July-December  2005)  were  examined  for  gas-
trointestinal NETs [5]. Cases were selected based on 
primary  site  code:  C160-9,  stomach;  C170-9,  small 
intestine; C181 appendix; C180, C182-189, and C260, 
colon;  and  C199  and  C209,  rectum.  The  following 
histology  codes  were  included  in  this  analysis  as 
NETs: 8240, malignant carcinoid tumor; 8241, enter-
ochromaffin  cell  carcinoid;  8245, adenocarcinoid  tu-
mor;  8246,  neuroendocrine  carcinoma;  and  8249, 
atypical carcinoid tumor. Non-first-tumors were ex-
cluded as well as stage 0 cases. 
 Racial/ethnic  groups  were  categorized  as  the 
following: non-Hispanic white, Hispanic white, black, 
Native American (American Indian/Alaska Native), 
and Asian. Patients of “other” or unknown race were 
excluded  from  analysis,  as  well  as  those  with  un-
known  age  at  diagnosis  or  unknown  historic  stage 
(localized, regional, or distant). Localized disease is 
defined as NETs that have not spread outside the wall 
of  the  primary  organ,  regional  metastasis  includes 
NETs  that  have  spread  beyond  the  wall  into  sur-
rounding tissue or lymph nodes, and distant metas-
tasis includes NETs that have spread to tissue or or-
gans away from the primary organ. Historic stage of 
diagnosis  was  used  for  analysis  rather  than  other 
staging systems in an effort to maintain consistency 
across  time.  Thus,  a  total  of  19,669  gastrointestinal 
NETs  were  included;  we  considered  only  hollow 
viscus  NETs  and  excluded  pancreatic  NETs  in  this 
study, since pancreatic NETs are often staged using 
the same staging system for pancreatic cancer. Geo-
graphic regions were categorized according to SEER 
registry  site:  West  (San  Francisco-Oakland  SMSA, 
Seattle/Puget  Sound,  Utah,  San  Jose-Monterey,  Los 
Angeles,  and  California  excluding  SF/SJM/LA), 
South (Atlanta metropolitan, rural Georgia, Kentucky, 
and Louisiana), East (Connecticut and New Jersey), 
Midwest (Detroit metropolitan and Iowa), Southwest 
(New Mexico), and HI/AK (Hawaii and Alaska Na-
tives). The latter two regions were excluded from re-
gion-stratified analyses due to small numbers. 
 Incidence rates each year between 1975 and 2008 
were calculated using SEER*Stat 7.0.4 for the original 
9 SEER registries, expressed per 100,000 person-years 
and age-adjusted to the 2000 US Standard Population 
(19 age groups – Census P25-1130) [6]. Separate rates 
were calculated by race (white and black) and geo-
graphic  region.  Trends  in  incidence  rates  over  time 
were tested using Poisson regression, using year of 
diagnosis  as  a  continuous  variable.  Multiplicative 
interactions  with  year  of  diagnosis  were  tested  by 
including an interaction term with race or region in 
the model and conducting a likelihood ratio test. 
 Cox proportional hazards regression was used 
to  compare  disease-specific  5-year  survival  rates 
across  decades,  using  the  most  recent  decade 
(2000-2008) as the reference group. The SEER database 
codes patients surviving less than 1 month as having 
zero time of survival; we redefined this zero survival 
time as 0.1 months. Models were adjusted for age at 
diagnosis (continuous), historic stage, race/ethnicity, 
sex, and registry. Differences in patient characteristics 
according to stage at diagnosis were tested for each 
anatomic  site  separately using  chi-square  tests  (sex, 
race/ethnicity, and geographic region) and one-way 
analysis  of  variance  (ANOVA;  age  at  diagnosis). 
Temporal trends were tested using year of diagnosis 
as  a  continuous  variable.  Stratified  analyses  were 
conducted for sex, race/ethnicity, and age (20-39 y, 
40-59 y, 60-79 y, and 80+ y). Multiplicative interac-
tions with year of diagnosis were tested by including 
an interaction term with sex, race, or age in the model 
and examining the P value of that term. All statistical 
analyses were performed using Stata 11.2 (StataCorp, 
College Station, TX). 
 
Results 
Demographics 
 Between 1975 and 2008 there were 19,669 indi-
viduals  with  primary  hollow  viscus  gastrointestinal 
NETs identified in the SEER database who met our 
inclusion  criteria.  Of  these,  1904  originated  in  the 
stomach,  7181  in  the  small  intestine,  982  in  the  ap-
pendix, 2806 in the colon, and 6796 in the rectum (Ta-
ble  1).  The  majority  of  individuals  diagnosed  with 
NETs were white and resided in the western part of 
the United States. There was no gender predilection 
for NETs of the small intestine or rectum, but NETs of 
the  stomach,  appendix,  and  colon  affected  women 
more commonly than men (chi-square test, P < 0.001, 
P  <  0.001,  and  P  =  0.010,  respectively).  Individuals 
diagnosed with NETs of the stomach, small intestine, 
or colon were older than those diagnosed with tumors 
of  the  appendix  or  rectum  (one-way  ANOVA,  P  < 
0.001).  Journal of Cancer 2012, 3 
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Table 1. Characteristics of SEER gastrointestinal NET 
patients (n = 19,669): %. 
  Stomach  
(n = 
1904) 
Small in-
testine  
(n = 7181) 
Appendix  
(n = 982) 
Colon  
(n = 
2806) 
Rectum  
(n = 
6796) 
Sex           
 Female  58.5  47.8  59.8  54.8  49.3 
 Male  41.5  52.2  40.2  45.2  50.7 
Age (y)           
 < 20  0.11  0.11  7.94  0.18  0.21 
 20-39  7.20  4.47  35.1  4.38  8.99 
 40-59  37.1  35.8  38.8  36.5  55.8 
 60-79  44.1  48.6  15.5  44.9  32.1 
 80+  11.5  11.0  2.65  14.0  2.87 
 mean ± SD  61.4 ± 
14.6 
62.8 ± 13.5  43.4 ± 
17.4 
63.3 ± 
13.9 
55.6 ± 
12.3 
Year of diagno-
sis 
         
 2000s  73.8  62.5  50.1  64.1  74.1 
 1990s  19.3  21.5  18.5  21.9  19.9 
 1980s  5.04  11.2  12.9  9.19  4.53 
 1970s  1.84  4.86  18.4  4.81  1.44 
Stage           
 Localized  77.9  34.4  61.2  31.7  93.2 
 Regional  8.14  37.1  26.9  30.3  2.74 
 Distant  14.0  28.5  11.9  38.0  4.06 
Race/ethnicity           
 Non-Hispanic 
white 
64.4  77.9  81.3  75.0  51.5 
 Hispanic white  14.8  5.67  6.11  6.24  9.64 
 Black  12.5  13.1  8.04  13.2  19.0 
 Asian  6.25  2.49  3.26  3.99  14.6 
 Oth-
er/unknown 
2.05  0.91  1.32  1.64  5.28 
Region           
 West  47.8  45.1  42.0  46.5  52.2 
 South  14.6  14.2  12.2  14.0  12.9 
 East  15.7  15.5  23.3  14.3  13.1 
 Midwest  14.5  19.9  17.4  20.4  13.3 
 Southwest  4.31  3.50  2.85  2.85  2.85 
 HI/AK  3.10  1.91  2.24  1.96  5.61 
 
 
Incidence 
 The  overall  incidence  rate  of  gastrointestinal 
NETs has increased since 1975 and is evident for all 
gastrointestinal organ sites (P < 0.001), except NETs 
originating in the appendix (P = 0.466; Figure 1). The 
rise in disease detection was markedly higher for tu-
mors of the small intestine and rectum than for tu-
mors of the stomach and colon, but it was significant 
for both whites and blacks at all four organ sites (P < 
0.001). We observed a significant race-by-year inter-
action for NETs of the rectum, such that the incidence 
rate  increased  at  a  higher  pace  among  blacks  than 
whites (P < 0.001). No other substantial race-by-year 
interactions  were  detected.  Furthermore,  incidence 
rates significantly increased across all geographic re-
gions  (P  <  0.001),  and  some  region-by-year  interac-
tions were observed. For small intestinal NETs, inci-
dence rates increased faster in the Midwest than in the 
other three regions (P = 0.040). For rectal NETs, inci-
dence rates increased more slowly in the East than in 
the other three regions (P < 0.001). In contrast, no sig-
nificant region-by-year interactions were observed for 
NETs of the stomach or colon. 
 We found some significant differences in stage 
of presentation according to site of disease. The ma-
jority of individuals with NETs of the stomach, rec-
tum,  and  appendix  were  diagnosed  with  localized 
disease, whereas detection of small intestinal and co-
lon  NETs  was  more  evenly  distributed  among  the 
three disease stages (Table 1). All sites, except stom-
ach, showed differential stage at diagnosis according 
to geographic region (Table 2). For example, the West 
had a disproportionately high number of distant ap-
pendiceal  NETs,  while  the  South  and  Midwest  had 
more regional cases, and the East had more localized 
cases.  Furthermore,  the  South  had  a  disproportion-
ately high number of localized small intestinal NETs, 
along with fewer distant rectal NETs but more distant 
colon NETs. In addition, the Midwest had a dispro-
portionately high number of distant rectal NETs. 
Survival Analysis 
 Several factors were noted to affect disease-free 
survival,  including  tumor  site.  NETs  of  the  rectum 
and appendix had the best prognosis, with a 95.6% 
and  90.3%  5-year  disease-specific  survival,  respec-
tively (Table 3). The 5-year survival for other gastro-
intestinal NETs was 86.2% for small intestine, 82.7% 
for stomach, and 67.4% for colon. Prognosis was also 
evaluated by decade of diagnosis. Although survival 
for individuals with NETs of the appendix appeared 
to have worsened since the 1970s in the crude model, 
there was no significant trend in survival rates over 
time after adjusting for age, stage, race/ethnicity, sex, 
and  registry  site  (Ptrend  =  0.779).  A  lack  of  survival 
difference over time was also noted for NETs of the 
rectum  (Ptrend  =  0.096)  and  stomach  (Ptrend  =  0.396). 
Notably,  survival  has  significantly  improved  every 
decade for NETs of the small intestine (Ptrend < 0.001) 
and colon (Ptrend = 0.002). 
 We stratified the analysis according to gender, 
race/ethnicity,  age,  and  geographic  region.  After 
stratification by gender, 5-year survival for NETs of 
the  small  intestine  improved  over  time  for  both  Journal of Cancer 2012, 3 
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women (Ptrend < 0.001) and men (Ptrend < 0.001; Table 
4). The same was true for NETs of the colon, though 
the trend was only marginally significant for women 
(Ptrend = 0.054, women; Ptrend = 0.010, men). No clear 
trends were observed for women or men for NETs of 
other organ sites. 
 Furthermore,  we  observed  no  significant 
year-by-race/ethnicity  interactions  (Table  5).  How-
ever, improvement in survival for NETs of the small 
intestine  was  evident  in  non-Hispanic  whites  only 
(Ptrend < 0.001). In contrast, survival for NETs of the 
colon  significantly  improved  for  both  non-Hispanic 
whites (Ptrend = 0.014) and blacks (Ptrend = 0.031). Sim-
ilarly, although no significant year-by-age interactions 
were detected, improvement in survival for NETs of 
the small intestine was most evident in patients age 
40-59  years  (Ptrend  =  0.003)  and  60-79  years  (Ptrend  < 
0.001; Table 6). Likewise, improvement in survival for 
NETs of the colon was strongest in patients age 40-59 
years (Ptrend = 0.009). 
 Region-stratified  analyses  were  restricted  to 
NETs of the small intestine and colon due to limited 
numbers of cases for other organ NETs. We observed 
a  significant  year-by-region  interaction  for  NETs  of 
the colon (P = 0.028), for which survival improvement 
across time was evident in the Midwest (Ptrend = 0.002) 
and South (Ptrend = 0.012), but not the West (Ptrend = 
0.553) or East (Ptrend = 0.165; Table 7). In contrast, sur-
vival for NETs of the small intestine improved in all 
geographic regions, though the trend was not signif-
icant in the South (Ptrend = 0.060). 
 
 
Figure 1. Incidence rates (age-adjusted, per 100,000) for neuroendocrine tumors (NETs) between 1975 and 2008 in 9 SEER registries. 
Incidence rates have significantly increased over time for NETs of the small intestine, rectum, colon, and stomach (all P < 0.001) but not 
for NETs of the appendix (P = 0.466). 
 
Table 2. Characteristics of SEER gastrointestinal NET patients, by stage at diagnosis (n = 19,669): %. 
Site  Characteristic  Localized  Regional  Distant  P1 
Appendix           
  Female  58.9  61.0  61.5  0.778 
  Age (y)         
   < 40  51.3  37.9  12.8   
   40-59  35.4  42.8  47.0   
   60-79  12.0  14.8  35.0   
   80+  1.33  4.55  5.13   
  Race/ethnicity        0.020  Journal of Cancer 2012, 3 
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   Non-Hispanic white  83.0  78.0  79.5   
   Hispanic white  6.49  5.30  5.98   
   Black  5.99  13.3  6.84   
   Asian  3.49  1.89  5.13   
   Other/unknown  1.00  1.52  2.56   
  Region        0.001 
   West  40.6  40.9  51.3   
   South  10.2  18.2  9.40   
   East  27.8  16.3  16.2   
   Midwest  16.5  19.7  17.1   
   Southwest  2.83  3.03  2.56   
   HI/AK  2.16  1.89  3.42   
Small intestine           
  Female  46.5  48.0  49.1  0.212 
  Age (y)         
   < 40  5.38  4.06  4.30   
   40-59  34.2  37.3  35.9   
   60-79  48.2  47.2  51.1   
   80+  12.3  11.5  8.74   
  Race/ethnicity        < 0.001 
   Non-Hispanic white  70.6  81.7  81.6   
   Hispanic white  6.55  4.85  5.67   
   Black  17.6  11.1  10.2   
   Asian  3.44  1.95  2.05   
   Other/unknown  1.78  0.41  0.49   
  Region        < 0.001 
   West  43.4  44.0  48.4   
   South  16.9  13.6  11.6   
   East  15.1  17.3  13.6   
   Midwest  18.6  20.0  21.3   
   Southwest  3.84  3.42  3.18   
   HI/AK  2.14  1.69  1.91   
Rectum           
  Female  49.7  48.9  40.9  0.018 
  Age (y)         
   < 40  9.47  7.53  3.99   
   40-59  56.9  39.8  42.8   
   60-79  31.1  45.7  45.7   
   80+  2.54  6.99  7.61   
  Race/ethnicity        < 0.001 
   Non-Hispanic white  51.0  58.6  57.3   
   Hispanic white  9.65  9.14  9.78   
   Black  19.0  16.7  22.8   
   Asian  14.8  14.5  8.70   
   Other/unknown  5.57  1.08  1.45   
  Region        < 0.001 
   West  52.2  50.5  54.0   
   South  13.1  12.9  7.97   
   East  13.0  14.0  14.9   
   Midwest  12.9  18.8  18.1   
   Southwest  2.84  1.61  3.99   
   HI/AK  5.90  2.15  1.09    Journal of Cancer 2012, 3 
 
http://www.jcancer.org 
297 
Stomach           
  Female  63.3  40.7  41.7  < 0.001 
  Age (y)         
   < 40  7.48  5.81  7.14   
   40-59  38.8  30.3  31.6   
   60-79  42.8  50.3  48.1   
   80+  11.0  13.6  13.2   
  Race/ethnicity        0.001 
   Non-Hispanic white  65.5  60.0  60.9   
   Hispanic white  14.8  13.6  15.4   
   Black  12.3  11.6  14.3   
   Asian  5.06  14.2  8.27   
   Other/unknown  2.36  0.65  1.13   
  Region        0.167 
   West  47.3  49.0  50.0   
   South  15.4  11.0  12.0   
   East  15.8  20.0  12.8   
   Midwest  14.1  12.9  17.7   
   Southwest  4.59  1.94  4.14   
   HI/AK  2.83  5.16  3.38   
Colon           
  Female  51.8  58.4  54.4  0.020 
  Age (y)         
   < 40  7.19  3.53  3.19   
   40-59  47.3  32.6  30.7   
   60-79  37.3  43.8  52.1   
   80+  8.20  20.1  14.0   
  Race/ethnicity        < 0.001 
   Non-Hispanic white  64.0  77.7  81.9   
   Hispanic white  7.64  5.76  5.45   
   Black  17.4  12.7  10.1   
   Asian  6.74  3.29  2.25   
   Other/unknown  4.16  0.59  0.38   
  Region        < 0.001 
   West  51.1  40.7  47.3   
   South  13.0  14.3  14.5   
   East  13.2  16.8  13.3   
   Midwest  17.4  22.2  21.4   
   Southwest  2.81  4.23  1.78   
   HI/AK  2.47  1.76  1.69   
1 P value from chi-square test (sex, race/ethnicity, and geographic region) or one-way analysis of variance (age at diagnosis). 
 
Table 3. Cox proportional hazards models for disease-specific 5-year survival in each decade. 
  n deaths/total (%)  Crude  
HR (95% CI) 
Adjusted1  
HR (95% CI) 
Appendix  95/982 (9.67)     
 2000s  45/492 (9.15)  1.00  1.00 
 1990s  35/182 (19.2)  1.73 (1.11–2.69)  2.09 (1.16–3.77) 
 1980s  11/127 (8.66)  0.75 (0.69–1.46)  0.80 (0.36–1.79) 
 1970s  4/181 (2.21)  0.18 (0.07–0.51)  1.08 (0.34–3.47) 
 Ptrend    0.004  0.779  Journal of Cancer 2012, 3 
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Small intestine  991/7181 (13.8)      
 2000s  450/4488 (10.0)  1.00  1.00 
 1990s  291/1540 (18.9)  1.47 (1.27–1.71)  1.43 (1.20–1.71) 
 1980s  170/804 (21.1)  1.80 (1.50–2.14)  1.70 (1.38–2.09) 
 1970s  80/349 (21.1)  1.97 (1.56–2.51)  1.82 (1.40–2.36) 
 Ptrend    < 0.001  < 0.001 
Rectum  300/6796 (4.41)     
 2000s  169/5037 (3.36)  1.00  1.00 
 1990s  18/1353 (5.99)  1.45 (1.11–1.89)  1.45 (1.07–1.97) 
 1980s  36/308 (11.7)  2.99 (2.09–4.28)  1.24 (0.82–1.88) 
 1970s  14/98 (14.3)  3.73 (2.16–6.44)  1.09 (0.59–2.03) 
 Ptrend    < 0.001  0.096 
Stomach  330/1904 (17.3)     
 2000s  216/1405 (15.4)  1.00  1.00 
 1990s  75/368 (20.4)  1.15 (0.89–1.50)  1.01 (0.74–1.37) 
 1980s  27/96 (28.1)  1.81 (1.21–2.69)  0.93 (0.60–1.45) 
 1970s  12/35 (34.3)  2.41 (1.34–4.30)  1.45 (0.78–2.68) 
 Ptrend    < 0.001  0.396 
Colon  916/2806 (32.6)     
 2000s  516/1798 (28.7)  1.00  1.00 
 1990s  236/615 (38.4)  1.21 (1.04–1.41)  1.10 (0.92–1.31) 
 1980s  106/258 (41.1)  1.38 (1.12–1.70)  1.21 (0.96–1.53) 
 1970s  58/135 (43.0)  1.63 (1.24–2.14)  1.37 (1.02–1.83) 
 Ptrend    < 0.001  0.002 
1 Adjusted for age (continuous), stage (localized vs. regional vs. distant), race/ethnicity (non-Hispanic white vs. Hispanic white vs. black vs. 
vs. Asian vs. other/unknown), sex, and registry site. 
 
Table 4. Cox proportional hazards models for disease-specific 5-year survival in each decade, stratified by gender. 
  Women  
HR (95% CI)1 
Men  
HR (95% CI)1 
Pinteraction2 
Appendix       
 2000s  1.00  1.00   
 1990s  1.64 (0.74–3.60)  3.02 (1.02–8.96)   
 1980s  0.64 (0.23–1.78)  0.97 (0.22–4.21)   
 1970s  0.62 (0.12–3.22)  1.91 (0.32–11.4)   
 Ptrend  0.303  0.356  0.344 
Small intestine       
 2000s  1.00  1.00   
 1990s  1.47 (1.14–1.88)  1.42 (1.11–1.82)   
 1980s  1.55 (1.15–2.10)  1.83 (1.37–2.44)   
 1970s  1.66 (1.14–2.43)  2.11 (1.46–3.05)   
 Ptrend  < 0.001  < 0.001  0.168 
Rectum       
 2000s  1.00  1.00   
 1990s  1.57 (0.98–2.53)  1.41 (0.93–2.14)   
 1980s  0.91 (0.44–1.87)  1.51 (0.89–2.56)   
 1970s  1.36 (0.46–3.97)  1.08 (0.50–2.33)   
 Ptrend  0.107  0.344  0.044 
Stomach       
 2000s  1.00  1.00   
 1990s  1.32 (0.80–2.18)  0.95 (0.64–1.42)   
 1980s  1.22 (0.60–2.46)  0.74 (0.40–1.40)    Journal of Cancer 2012, 3 
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 1970s  1.33 (0.53–3.36)  1.43 (0.59–3.50)   
 Ptrend  0.369  0.758  0.336 
Colon       
 2000s  1.00  1.00   
 1990s  1.04 (0.82–1.30)  1.18 (0.89–1.56)   
 1980s  1.27 (0.94–1.71)  1.16 (0.79–1.71)   
 1970s  1.15 (0.77–1.71)  1.78 (1.16–2.75)   
 Ptrend  0.054  0.010  0.910 
1 Adjusted for age (continuous), stage (localized vs. regional vs. distant), race/ethnicity (non-Hispanic white vs. Hispanic white vs. black vs. 
Native American vs. Asian), and registry site. 
2 P value for interaction term between sex and year of diagnosis (continuous) in Cox proportional hazards model. 
 
Table 5. Cox proportional hazards models for disease-specific 5-year survival in each decade, stratified by race/ethnicity. 
  Non-Hispanic white  
HR (95% CI)1 
Hispanic white  
HR (95% CI)1 
Black  
HR (95% CI)1 
Asian  
HR (95% CI)1 
Pinteraction2 
Small intestine           
 2000s  1.00  1.00  1.00  1.00   
 1990s  1.35 (1.11–1.64)  2.00 (1.02–3.90)  1.41 (0.84–2.36)  2.35 (0.64–8.59)   
 1980s  1.72 (1.37–2.15)  1.35 (0.41–4.41)  1.36 (0.73–2.53)  1.53 (0.38–6.24)   
 1970s  1.97 (1.49–2.60)  n/a  1.01 (0.38–2.68)  n/a   
 Ptrend  < 0.001  0.467  0.235  0.423  0.957 
Rectum           
 2000s  1.00  1.00  1.00  1.00   
 1990s  1.56 (1.03–2.38)  1.29 (0.36–4.70)  1.61 (0.85–3.07)  0.97 (0.29–3.25)   
 1980s  1.05 (0.62–1.78)  n/a  1.70 (0.71–4.07)  4.74 (0.87–25.8)   
 1970s  1.62 (0.81–3.23)  n/a  0.59 (0.13–2.70)  n/a   
 Ptrend  0.083  0.108  0.992  0.310  0.658 
Stomach           
 2000s  1.00  1.00  1.00  1.00   
 1990s  1.24 (0.84–1.85)  0.71 (0.29–1.75)  0.58 (0.23–1.46)  1.22 (0.46–3.26)   
 1980s  1.03 (0.59–1.81)  n/a  1.06 (0.31–3.62)  0.49 (0.12–1.94)   
 1970s  1.50 (0.78–2.92)  n/a  n/a  14.2 (1.37–148.)   
 Ptrend  0.317  0.315  0.584  0.850  0.517 
Colon           
 2000s  1.00  1.00  1.00  1.00   
 1990s  1.09 (0.90–1.33)  1.66 (0.75–3.64)  1.30 (0.72–2.33)  0.79 (0.31–2.02)   
 1980s  1.19 (0.92–1.53)  n/a  3.20 (1.41–7.27)  0.15 (0.03–0.81)   
 1970s  1.34 (0.99–1.83)  n/a  1.33 (0.30–5.95)  1.15 (0.14–9.77)   
 Ptrend  0.014  0.117  0.031  0.209  0.240 
Note: Appendiceal NETs were excluded from this analysis due to small numbers. 
1 Adjusted for age (continuous), stage (localized vs. regional vs. distant), sex, and registry site 
2 P value for interaction term between race and year of diagnosis (continuous) in Cox proportional hazards model 
 
Table 6. Cox proportional hazards models for disease-specific 5-year survival in each decade, stratified by age. 
  < 40 y  
HR (95% CI)1 
40-59 y  
HR (95% CI)1 
60-79 y  
HR (95% CI)1 
80+ y  
HR (95% CI)1 
Pinteraction2 
Small intestine           
 2000s  1.00  1.00  1.00  1.00   
 1990s  1.08 (0.27–4.24)  1.36 (0.93–1.99)  1.52 (1.21–1.92)  1.29 (0.86–1.93)   
 1980s  0.82 (0.13–4.95)  1.42 (0.89–2.26)  1.84 (1.41–2.41)  1.55 (0.95–2.52)   
 1970s  3.35 (0.72–15.6)  2.16 (1.29–3.62)  1.64 (1.15–2.35)  1.38 (0.65–2.91)    Journal of Cancer 2012, 3 
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 Ptrend  0.306  0.003  < 0.001  0.140  0.183 
Rectum           
 2000s  1.00  1.00  1.00  1.00   
 1990s  0.26 (0.01–6.63)  1.42 (0.85–2.37)  1.56 (0.98–2.50)  1.43 (0.35–5.86)   
 1980s  n/a  1.61 (0.78–3.33)  1.18 (0.65–2.14)  0.78 (0.11–5.33)   
 1970s  n/a  1.09 (0.24–4.91)  1.27 (0.59–2.70)  n/a   
 Ptrend  0.123  0.173  0.177  0.718  0.711 
Stomach           
 2000s  1.00  1.00  1.00  1.00   
 1990s  n/a  0.50 (0.22–1.11)  1.30 (0.87–1.95)  1.15 (0.51–2.60)   
 1980s  n/a  0.77 (0.26–2.28)  0.74 (0.38–1.42)  1.57 (0.47–5.23)   
 1970s  n/a  0.49 (0.12–1.97)  1.38 (0.56–3.40)  2.35 (0.39–14.3)   
 Ptrend  n/a  0.320  0.377  0.430  0.540 
Colon           
 2000s  1.00  1.00  1.00  1.00   
 1990s  1.32 (0.38–4.56)  1.22 (0.82–1.81)  1.04 (0.82–1.31)  1.04 (0.70–1.55)   
 1980s  n/a  1.41 (0.86–2.30)  1.08 (0.78–1.50)  1.16 (0.70–1.92)   
 1970s  n/a  1.81 (1.01–3.26)  1.07 (0.72–1.61)  1.33 (0.68–2.61)   
 Ptrend  0.796  0.009  0.195  0.396  0.786 
Note: Appendiceal NETs were excluded from this analysis due to small numbers. 
1 Adjusted for stage (localized vs. regional vs. distant), race/ethnicity (non-Hispanic white vs. Hispanic white vs. black vs. Native American 
vs. Asian), and registry site. 
2 P value for interaction term between age (continuous) and year of diagnosis (continuous) in Cox proportional hazards model. 
 
Table 7. Cox proportional hazards models for disease-specific 5-year survival in each decade, stratified by geographic 
region. 
  West 
HR (95% CI)1 
South 
HR (95% CI)1 
East 
HR (95% CI)1 
Midwest 
HR (95% CI)1 
Pinteraction2 
Small intestine           
 2000s  1.00  1.00  1.00  1.00   
 1990s  1.57 (1.23–2.00)  1.64 (0.64–4.20)  1.49 (0.81–2.72)  1.21 (0.88–1.67)   
 1980s  1.79 (1.28–2.50)  2.41 (0.88–6.57)  1.92 (1.02–3.62)  1.47 (1.05 (2.07)   
 1970s  1.89 (1.25–2.86)  4.11 (1.18–14.3)  1.57 (0.70–3.54)  1.74 (1.14–2.67)   
 Ptrend  < 0.001  0.060  0.041  0.001  0.865 
Colon           
 2000s  1.00  1.00  1.00  1.00   
 1990s  0.90 (0.70–1.16)  2.45 (1.18–5.11)  0.97 (0.55–1.72)  1.37 (0.97–1.93)   
 1980s  0.84 (0.54–1.30)  3.37 (1.46–7.77)  0.84 (0.38–1.88)  1.61 (1.10–2.36)   
 1970s  0.72 (0.42–1.22)  1.85 (0.53–6.51)  1.70 (0.80–3.65)  2.01 (1.23–3.29)   
 Ptrend  0.553  0.012  0.165  0.002  0.028 
Note: Organ sites with insufficient numbers were excluded from analysis, as were the Southwest and HI/AK regions. 
1 Adjusted for age at diagnosis (continuous), stage (localized vs. regional vs. distant), sex (female vs. male), race/ethnicity (non-Hispanic 
white vs. Hispanic white vs. black vs. Native American vs. Asian), and registry site. 
2 P value for interaction term between age (continuous) and year of diagnosis (continuous) in Cox proportional hazards model. 
 
 
Discussion 
Our study based on the latest SEER data exam-
ines  the  incidence  and  survival  of  gastrointestinal 
NETs according to gender, race/ethnicity, age, geo-
graphic  region,  and  time.  To  our  knowledge  this 
study is one of the largest and most up-to-date reports 
of primary occurrences of gastrointestinal NETs strat-
ified over time and geographic regions. As reported in 
other studies, our examination reveals increased in-
cidence  of  gastrointestinal  NETs  [7],  particularly  of 
the small intestine and colon. This increase may par-
tially  be  attributed  to  improved  detection  through 
advancements in endoscopic and radiologic imaging  Journal of Cancer 2012, 3 
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techniques.  The  rate  of  increase,  however,  varied 
across regions; incidence of small intestinal NETs in 
the Midwest increased most rapidly compared with 
other regions, whereas rectal NETs in the East had the 
slowest  increase.  The  differences  observed  among 
regions may be influenced by external factors, such as 
completeness of data acquisition, rather than a true 
difference in the epidemiology of the disease. 
Yao et al [8] reported an increase in incidence and 
prevalence of NETs without significant differences by 
gender. However, we found that overall prevalence of 
stomach, appendiceal, and colon NETs was higher in 
women than men, a finding consistent with other re-
ports  [9].  Our  study  demonstrated  a  significant  in-
crease in the incidence of rectal NETs that was more 
substantial among blacks than whites, an observation 
in agreement with other studies [10, 11]. Although we 
did not investigate the cause of this racial disparity, 
prior published reports have demonstrated that mi-
norities undergo less frequent screening colonoscopy 
than  whites,  but  they  are  more  likely  to  have  sig-
moidoscopies performed at appropriate intervals [12]. 
We found that NETs of the rectum and appendix 
had the best prognosis, with 95.6% and 90.3% 5-year 
disease-specific  survival,  respectively,  whereas  sur-
vival  for  the  remaining  gastrointestinal  NETs  was 
86.2%  for  small  intestine,  82.7%  for  stomach,  and 
67.4%  for  colon.  These  findings  agree  with  other 
studies [13, 14] that have shown that NETs of the co-
lon and stomach seem to have worse prognosis. What 
is  promising  is  that  survival  rates  for  colon  NETs 
seem to have significantly improved over time. Also, 
since  surgery  is  the  mainstay  treatment  for  colon 
NETs,  an  increase  in  screening  colonoscopies  [15] 
might  have  led  to  earlier  detection  of  those  lesions 
and, therefore, to a speedier definite treatment. The 
increased number of screening colonoscopies perhaps 
also explains how improved survival in colon NETs is 
seen primarily among patients age 40-59 years, when 
first colonoscopies are most likely to occur. We also 
observed an improvement in survival of small intes-
tinal  NETs  over  time,  whereas  survival  rates  were 
more  static  for  stomach,  appendiceal,  and  rectal 
NETs. However, the improved survival for colon and 
small  intestinal  NETs  was  limited  to  non-Hispanic 
whites and not observed among blacks or Hispanics. 
One study examined the impact of racial clustering 
and  segregation  on  access  to  cancer  specialists  and 
concluded  that  there  is  an  inverse  relationship  be-
tween the number of specialists and the number of 
minorities  in  various  geographic  regions  [16].  Re-
garding  the  prognostic  outcomes  of  gastrointestinal 
NETs across regions, we observed a statistically sig-
nificant improvement in the prognosis of small intes-
tinal NETs except for patients in the South. This dis-
parity is difficult to interpret and it could be second-
ary to multiple etiologies that were not investigated in 
our analyses; therefore, no conclusions can be drawn 
at this juncture. 
This study has certain limitations inherent to all 
studies  that  rely  on  retrospective  data.  Incomplete 
data may have had the greatest impact on our results. 
For instance, the SEER database may lack information 
on a high number of gastrointestinal NETs that were 
not registered, secondary to the fact that the vast ma-
jority  of  these  lesions  are  benign.  This  gap  in  data 
availability could affect our results and conclusions. 
Also,  the  influence  of  geographic  region  is  limited 
since  the  SEER  registry  does  not  incorporate  infor-
mation from every state, and there is disproportionate 
representation of patients  in the  West, which could 
also influence our gender and racial analyses. How-
ever, the SEER database is one of the largest registries 
that allow comparative analysis of individual tumors. 
This study is also limited by differences in data input 
over  time,  specifically  stage  of  presentation.  To  ac-
count for this, we attempted to standardize stage of 
presentation  by  excluding  newer  staging  classifica-
tions.  Furthermore,  we  excluded  non-first-tumors, 
including  multiple  NET  sites  reported  on  the  same 
individual after the initial diagnosis, in order to ex-
amine accurately the incidence of these lesions. 
Conclusion 
To conclude, gastrointestinal NETs are a disease 
entity with increased incidence rates among all ana-
tomic sites, except for appendiceal NETs. However, 
disparities are seen in survival rates according to an-
atomic  location,  race/ethnicity,  and  geographic  re-
gion.  Established  national  guidelines  of  detection, 
staging,  and  treatment  could  perhaps  provide  a 
more-even prognostic stand among patients afflicted 
with the disease. 
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